Health Technology
Swiss companies developing health technologies
Developing medical devices, diagnostics, and healthcare software platforms defines the health technology sector. Regulatory approval timelines and shifting Medicare reimbursement models constantly inject liquidity into these equities. Currently, Novartis AG dominates trading volume, whereas Inovio Pharmaceuticals, Inc. logs the strongest 24-hour performance. The table below organizes vital technical and fundamental data points.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.09 T CHF | 1,180 CHF | +23.56% | 1 | 0.31 | 46.38 | 25.44 CHF | +57.99% | 0.47% | Strong buy |
| LLYEli Lilly and Company | 1.09 T CHF | 1,104.870 CHF | −5.56% | 6 | 0.13 | 43.42 | 25.44 CHF | +57.99% | 0.47% | Strong buy |
 JNJJohnson & Johnson | 543.72 B CHF | 227.679 CHF | +3.11% | 12 | 0.87 | 41.32 | 5.51 CHF | −33.23% | 1.91% | Buy |
| JNJ.USDJohnson & Johnson | 543.72 B CHF | 261.25 USD | 0.00% | 177 | 0.35 | 39.63 | 5.51 CHF | −36.38% | 1.91% | Buy |
 4ABAbbVie, Inc. | 425.98 B CHF | 240.889 CHF | +13.10% | 1.35 K | 9.21 | 49.60 | 4.86 CHF | +360.13% | 2.35% | Buy |
| ABBVAbbVie, Inc. | 425.98 B CHF | 236.65 CHF | +1.24% | 20 | 0.30 | 48.72 | 4.86 CHF | +360.13% | 2.35% | Buy |
 RHORoche Holding Ltd | 315.59 B CHF | 405.099 CHF | −0.76% | 15 | 0.73 | 26.43 | 15.33 CHF | +30.49% | 2.69% | Buy |
| ROPRoche Holding Ltd | 315.59 B CHF | 390.3 CHF | −0.36% | 1.44 M | 1.30 | 25.47 | 15.33 CHF | +30.49% | 2.48% | Buy |
| ROPRoche Holding Ltd | 315.59 B CHF | 386.324 CHF | −1.65% | 344 | 0.41 | 25.21 | 15.33 CHF | +30.49% | 2.48% | Buy |
| RORoche Holding Ltd | 315.59 B CHF | 400.0 CHF | +0.25% | 64.81 K | 2.40 | 26.10 | 15.33 CHF | +30.49% | 2.69% | Buy |
 6MKMerck & Co., Inc. | 303.22 B CHF | 123.142 CHF | +4.32% | 16 | 0.65 | 150.44 | 0.82 CHF | −86.41% | 2.26% | Buy |
| MRK.USDMerck & Co., Inc. | 303.22 B CHF | 151.22 USD | 0.00% | 1.24 K | 0.89 | 154.43 | 0.82 CHF | −87.05% | 2.26% | Buy |
 NOVNEENovartis AG TEMP | 245.77 B CHF | 132.56 CHF | −1.88% | 130 K | 0.45 | 31.95 | 4.15 CHF | −33.04% | 2.76% | No rating |
| NOTNovartis AG | 245.77 B CHF | 132.760 CHF | −1.75% | 127 | 0.24 | 32.00 | 4.15 CHF | −33.04% | 2.76% | Neutral |
| NOVNNovartis AG | 245.77 B CHF | 133.08 CHF | −0.78% | 4.01 M | 1.00 | 32.07 | 4.15 CHF | −33.04% | 2.76% | Neutral |
 ZEGAstraZeneca PLC | 239.39 B CHF | 155.416 CHF | +1.57% | 211 | 9.91 | 26.62 | 5.84 CHF | +18.22% | 1.70% | Buy |
 TN8Thermo Fisher Scientific Inc. | 213.87 B CHF | 546.250 CHF | −2.06% | 2 | 0.65 | 34.48 | 15.84 CHF | +14.93% | 0.26% | Buy |
 AMGAmgen Inc. | 211.44 B CHF | 388.337 CHF | +1.70% | 9 | 0.76 | 26.94 | 14.41 CHF | +39.89% | 2.08% | Neutral |
 GISGilead Sciences, Inc. | 176.9 B CHF | 134.099 CHF | −5.57% | 20 | 0.15 | — | −2.63 CHF | −151.18% | 1.86% | Buy |
 ABLAbbott Laboratories | 163.38 B CHF | 94.775 CHF | +6.44% | 631 | 30.05 | 41.86 | 2.26 CHF | −64.34% | 2.18% | Buy |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 154.8 B CHF | 33.873 CHF | +4.89% | 30 | 0.03 | 10.21 | 3.32 CHF | +21.39% | 2.92% | Neutral |
| NOVNovo Nordisk A/S Class B | 154.8 B CHF | 33.068 CHF | +0.66% | 248 | 0.14 | 10.27 | 3.22 CHF | +10.70% | 4.10% | Neutral |
 PFEPfizer Inc. | 143.45 B CHF | 23.577 CHF | −5.69% | 4.31 K | 10.28 | 40.34 | 0.58 CHF | −57.23% | 5.59% | Neutral |
 IUI1Intuitive Surgical, Inc. | 136.6 B CHF | 375.728 CHF | −4.11% | 25 | 1.59 | 54.38 | 6.91 CHF | +14.81% | 0.00% | Buy |
 DAPDanaher Corporation | 135.1 B CHF | 187.464 CHF | −1.94% | 1.65 K | 44.59 | 36.72 | 5.11 CHF | +31.91% | 0.65% | Buy |
 VX1Vertex Pharmaceuticals Incorporated | 113.78 B CHF | 439.008 CHF | −2.56% | 10 | 0.30 | 33.78 | 12.99 CHF | +14.99% | 0.00% | Buy |
 2M6Medtronic Plc | 109.74 B CHF | 85.457 CHF | −0.24% | 4 | 0.15 | 26.04 | 3.28 CHF | +11.14% | 2.72% | Buy |
 BRMBristol-Myers Squibb Company | 107.25 B CHF | 51.175 CHF | +1.34% | 10 | 0.03 | 13.57 | 3.77 CHF | +59.93% | 3.93% | Buy |
 SYKStryker Corporation | 105.69 B CHF | 257.002 CHF | +2.09% | 7 | 0.13 | 32.75 | 7.85 CHF | +29.36% | 1.04% | Buy |
 SANSanofi SA | 92.58 B CHF | 67.98 CHF | 0.00% | 450 | 0.13 | 22.12 | 3.07 CHF | −36.38% | 4.90% | Buy |
| SNWSanofi SA | 92.58 B CHF | 77.442 CHF | +6.14% | 495 | 2.82 | 25.20 | 3.07 CHF | −36.38% | 4.90% | Buy |
 MRNAModerna, Inc. | 84.32 B CHF | 161.56 CHF | −20.41% | 8 | — | — | −6.45 CHF | −8.21% | 0.00% | Neutral |
| 0QFModerna, Inc. | 84.32 B CHF | 214.368 CHF | +8.91% | 2.19 K | 10.49 | — | −6.45 CHF | −8.21% | 0.00% | Neutral |
| MRNA.USDModerna, Inc. | 84.32 B CHF | 226.80 USD | 0.00% | 1.93 K | 1.55 | — | −6.45 CHF | −6.20% | 0.00% | Neutral |
 GS71GSK plc | 83.39 B CHF | 20.522 CHF | +1.52% | 3 | 0.04 | 17.34 | 1.18 CHF | −17.14% | 3.60% | Neutral |
 ESLEssilorLuxottica SA | 80.36 B CHF | 175.776 CHF | +9.63% | 100 | 1.13 | 35.58 | 4.94 CHF | +2.56% | 2.12% | Buy |
| EL1EssilorLuxottica SA | 80.36 B CHF | 179.30 CHF | 0.00% | 1.73 K | 1.57 | 36.29 | 4.94 CHF | +2.56% | 2.12% | Buy |
 MRKMerck KGaA | 60.03 B CHF | 138.411 CHF | +6.22% | 200 | 1.68 | 27.50 | 5.03 CHF | −18.23% | 1.46% | Buy |
 BSXBoston Scientific Corporation | 54.29 B CHF | 37.640 CHF | −0.39% | 500 | 2.74 | 19.06 | 1.97 CHF | +32.59% | 0.00% | Buy |
 CSJCSL Limited | 54.2 B CHF | 113.768 CHF | −1.02% | 386 | 1.17 | — | −4.25 CHF | −186.00% | 2.05% | Buy |
 UNCUCB S.A. | 49.28 B CHF | 254.278 CHF | +5.56% | 30 | 1.03 | 24.36 | 10.44 CHF | +62.96% | 0.36% | Buy |
 BAYNBayer AG | 48.9 B CHF | 50.052 CHF | −2.26% | 480 | 0.51 | — | −1.63 CHF | +49.77% | 0.20% | Buy |
| BAYNBayer AG | 48.9 B CHF | 43.46 CHF | 0.00% | 600 | 0.69 | — | −1.63 CHF | +49.77% | 0.20% | Buy |
 SHLSiemens Healthineers AG | 45.93 B CHF | 41.12 CHF | +11.14% | 25 | 0.02 | 22.56 | 1.82 CHF | +1.10% | 2.23% | Buy |
| SHLSiemens Healthineers AG | 45.93 B CHF | 40.107 CHF | −2.47% | 4 | 0.06 | 22.01 | 1.82 CHF | +1.10% | 2.23% | Buy |
 GALDGalderma Group AG | 45.37 B CHF | 189.334 CHF | −3.60% | 213 | 0.88 | 65.20 | 2.90 CHF | +110.71% | 0.18% | Buy |
| GALDGalderma Group AG | 45.37 B CHF | 191.75 CHF | −1.74% | 580.42 K | 1.03 | 66.03 | 2.90 CHF | +110.71% | 0.18% | Buy |
 LO3Lonza Group AG | 45.09 B CHF | 658.428 CHF | −2.15% | 34 | 0.12 | — | −1.55 CHF | −115.18% | 0.76% | Buy |
| LONNLonza Group AG | 45.09 B CHF | 663.4 CHF | −1.34% | 212.06 K | 1.42 | — | −1.55 CHF | −115.18% | 0.76% | Buy |
 IX1IDEXX Laboratories, Inc. | 44.99 B CHF | 561.726 CHF | +28.10% | 100 | 4.37 | 45.29 | 12.40 CHF | +23.43% | 0.00% | Buy |
 SDZSandoz Group Ltd | 36.14 B CHF | 83.78 CHF | +0.19% | 893 K | 0.61 | 71.16 | 1.18 CHF | +166.48% | 0.97% | Neutral |
| D8YSandoz Group Ltd | 36.14 B CHF | 83.263 CHF | +0.29% | 1.07 K | 1.70 | 70.72 | 1.18 CHF | +166.48% | 0.97% | Neutral |
 RVMDRevolution Medicines, Inc. | 34.99 B CHF | 150.462 CHF | −4.57% | 59 | 0.85 | — | −7.13 CHF | −99.36% | 0.00% | Strong buy |
 2U3Alcon AG | 31.62 B CHF | 60.879 CHF | −3.84% | 1.21 K | 1.58 | 58.72 | 1.04 CHF | −44.92% | 0.44% | Buy |
| ALCAlcon AG | 31.62 B CHF | 61.30 CHF | −2.36% | 1.23 M | 1.27 | 59.12 | 1.04 CHF | −44.92% | 0.44% | Buy |
 ZOEZoetis, Inc. Class A | 30.13 B CHF | 65.569 CHF | +0.36% | 10 | 0.21 | 13.34 | 4.91 CHF | +6.56% | 2.38% | Neutral |
 DC4DexCom, Inc. | 26.97 B CHF | 64.471 CHF | −10.31% | 936 | 7.81 | 30.23 | 2.13 CHF | +49.03% | 0.00% | Strong buy |
 IM8NInsmed Incorporated | 19.73 B CHF | 91.668 CHF | −4.48% | 48 | — | — | −2.35 CHF | +52.19% | 0.00% | Strong buy |
 22UABioNTech SE Sponsored ADRDR | 18.62 B CHF | 70.648 CHF | −5.05% | 33 | 0.78 | — | −6.34 CHF | −399.64% | 0.00% | Buy |
 VTRSViatris, Inc. | 18.04 B CHF | 15.755 CHF | +4.80% | 74 | 1.31 | — | −0.29 CHF | +87.49% | 2.50% | Buy |
 DULAlnylam Pharmaceuticals, Inc | 17.64 B CHF | 138.579 CHF | −27.27% | 100 | 1.99 | 8.37 | 16.55 CHF | +8,543.33% | 0.00% | Buy |
 ZBHZimmer Biomet Holdings, Inc. | 17.17 B CHF | 76.0 CHF | +1.33% | 34 | 0.40 | 23.03 | 3.30 CHF | +2.53% | 0.87% | Neutral |
 STMNStraumann Holding AG | 17.12 B CHF | 104.50 CHF | −1.28% | 363.31 K | 0.79 | 45.17 | 2.31 CHF | −5.94% | 0.93% | Buy |
| QS51Straumann Holding AG | 17.12 B CHF | 106.125 CHF | −0.81% | 103 | 0.69 | 45.87 | 2.31 CHF | −5.94% | 0.93% | Buy |
 SOONSonova Holding AG | 16.68 B CHF | 288.0 CHF | −1.44% | 197.29 K | 1.42 | 39.88 | 7.22 CHF | −20.12% | 1.62% | Neutral |
| PHBNSonova Holding AG | 16.68 B CHF | 287.176 CHF | −1.86% | 128 | 0.34 | 39.77 | 7.22 CHF | −20.12% | 1.62% | Neutral |
 EX9Exelixis, Inc. | 14.51 B CHF | 53.452 CHF | +0.45% | 400 | 1.21 | 19.14 | 2.79 CHF | +47.64% | 0.00% | Buy |
 CBHDColoplast A/S Class B | 14.4 B CHF | 59.193 CHF | +1.18% | 2 K | 11.23 | 34.34 | 1.72 CHF | −14.44% | 4.40% | Neutral |
 WDH1Demant A/S | 9.42 B CHF | 45.623 CHF | +35.57% | 7 K | 40.70 | 48.03 | 0.95 CHF | −29.67% | 0.00% | Buy |
 QGENQIAGEN NV | 8.58 B CHF | 41.772 CHF | +40.91% | 10 | 0.10 | 26.25 | 1.59 CHF | +11.53% | 0.69% | Neutral |
 YDO1Madrigal Pharmaceuticals, Inc. | 7.6 B CHF | 358.641 CHF | −0.42% | 12 | 0.38 | — | −5.00 CHF | +51.78% | 0.00% | Strong buy |
 HDP1Arrowhead Pharmaceuticals, Inc. | 7.12 B CHF | 50.112 CHF | −7.82% | 2 K | 17.39 | — | −1.81 CHF | −80.90% | 0.00% | Strong buy |
 BANBBachem Holding AG Class B | 6.12 B CHF | 79.70 CHF | −0.06% | 58.18 K | 0.78 | 40.10 | 1.99 CHF | +11.05% | 1.10% | Buy |
| BANBBachem Holding AG Class B | 6.12 B CHF | 78.273 CHF | −3.74% | 12 | 0.15 | 39.38 | 1.99 CHF | +11.05% | 1.10% | Buy |
 OWXYpsomed Holding AG | 5.28 B CHF | 387.308 CHF | −4.22% | 1 | 0.04 | 23.76 | 16.30 CHF | +154.29% | 1.10% | Buy |
| YPSNYpsomed Holding AG | 5.28 B CHF | 394.4 CHF | −0.05% | 8.88 K | 0.79 | 24.20 | 16.30 CHF | +154.29% | 1.10% | Buy |
 1CGCRISPR Therapeutics AG | 4.11 B CHF | 40.056 CHF | −2.75% | 600 | 1.15 | — | −3.97 CHF | +10.71% | 0.00% | Buy |
 SFZNSiegfried Holding AG | 3.38 B CHF | 71.467 CHF | −3.66% | 32 | 0.16 | 18.28 | 3.91 CHF | +11.09% | 0.53% | Buy |
| SFZNSiegfried Holding AG | 3.38 B CHF | 72.00 CHF | −1.37% | 104.69 K | 0.94 | 18.41 | 3.91 CHF | +11.09% | 0.53% | Buy |
 IOVAIovance Biotherapeutics Inc | 3.22 B CHF | 7.100 CHF | −40.91% | 300 | — | — | −0.58 CHF | +40.09% | 0.00% | Buy |
 FIEFielmann Group AG | 3.19 B CHF | 36.668 CHF | +1.13% | 1 K | 6.49 | 15.75 | 2.33 CHF | +23.36% | 3.38% | Buy |
 TENTecan Group AG | 3.14 B CHF | 253.933 CHF | −4.60% | 56 | 1.10 | — | −9.16 CHF | −284.91% | 1.23% | Buy |
| TECNTecan Group AG | 3.14 B CHF | 257.6 CHF | −1.68% | 75.47 K | 0.91 | — | −9.16 CHF | −284.91% | 1.23% | Buy |
 AFXCarl Zeiss Meditec AG | 2.94 B CHF | 32.719 CHF | +1.21% | 100 | 0.21 | 32.70 | 1.00 CHF | −41.01% | 1.54% | Sell |
 MOVEMedacta Group SA | 2.48 B CHF | 106.4 CHF | −13.64% | 142.07 K | 4.92 | 29.74 | 3.58 CHF | −20.27% | 0.89% | Buy |
| 6MDMedacta Group SA | 2.48 B CHF | 106.788 CHF | −10.36% | 170 | 1.81 | 29.85 | 3.58 CHF | −20.27% | 0.89% | Buy |
 EZP1COMET Holding AG | 2.48 B CHF | 304.344 CHF | +2.26% | 4 | 0.08 | 132.65 | 2.29 CHF | −54.20% | 0.16% | Strong buy |
| COTNCOMET Holding AG | 2.48 B CHF | 298.0 CHF | −0.13% | 57.39 K | 1.51 | 129.88 | 2.29 CHF | −54.20% | 0.16% | Strong buy |
 RXRXRecursion Pharmaceuticals, Inc. Class A | 1.98 B CHF | 3.117 CHF | −4.45% | 4 K | 5.28 | — | −0.75 CHF | +48.25% | 0.00% | Buy |
 METNMetall Zug AG Class B | 1.8 B CHF | 835 CHF | 0.00% | 228 | 2.26 | — | −12.44 CHF | +56.17% | 0.00% | Neutral |
| NDH1Metall Zug AG Class B | 1.8 B CHF | 820.202 CHF | −0.27% | 2 | 0.21 | — | −12.44 CHF | +56.17% | 0.00% | Neutral |
 SKANSKAN Group AG | 1.61 B CHF | 69.7 CHF | −0.99% | 33.43 K | 0.94 | 52.26 | 1.33 CHF | +85.35% | 0.31% | Strong buy |
| 7VGSKAN Group AG | 1.61 B CHF | 73.514 CHF | +1.51% | 41 | 0.40 | 55.12 | 1.33 CHF | +85.35% | 0.31% | Strong buy |
 MEDMedartis Holding AG | 1.51 B CHF | 109.6 CHF | +2.05% | 14.27 K | 0.78 | 91.44 | 1.20 CHF | — | 0.00% | Strong buy |
 NVV1Novavax, Inc. | 1.44 B CHF | 8.008 CHF | −3.65% | 500 | 1.61 | — | −1.23 CHF | −168.74% | 0.00% | Buy |
 PPGNPolyPeptide Group AG | 1.36 B CHF | 40.05 CHF | −1.11% | 21.45 K | 0.97 | 99.08 | 0.40 CHF | — | 0.00% | Neutral |
| 8H0PolyPeptide Group AG | 1.36 B CHF | 43.866 CHF | −0.37% | 400 | 0.36 | 108.53 | 0.40 CHF | — | 0.00% | Neutral |
| PPPGNEPolyPeptide Group AG TEMP | 1.36 B CHF | 44.00 CHF | +0.34% | 1.97 K | 0.19 | 108.86 | 0.40 CHF | — | 0.00% | No rating |
 19TIdorsia Ltd. | 1.19 B CHF | 4.023 CHF | −8.69% | 100 | 0.08 | — | −1.11 CHF | −66.32% | 0.00% | Neutral |
| IDIAIdorsia Ltd. | 1.19 B CHF | 4.058 CHF | −3.38% | 997.2 K | 1.24 | — | −1.11 CHF | −66.32% | 0.00% | Neutral |